INTERVEST Exec On Challenges Limiting Korea’s Global Pharma Funds
Executive Summary
INTERVEST manages one of South Korea’s policy funds supporting the biopharma and healthcare industries. Executive managing director Junghee Lim sat down with Scrip to talk about challenges faced by venture capitals managing these funds, and why they may be a government program that Korea eventually abandons.
You may also be interested in...
More Govt Support For Pharma As Korea Plans New Fund
Following the successful launch of pharma development funds in the past few years, South Korea's health ministry is planning to create a new fund this year to further support domestic pharma firms' efforts to enter overseas markets and spur private sector investment in the broader healthcare industry.
Korea Govt Partners With J&J To Bring In Local JLABS Site
In collaboration with the national health ministry, J&J’s JLAB program is coming to South Korea as its third destination in Asia, underscoring the country’s increasing need to access multinationals’ know-how and its growing impact on the global biotech landscape and innovation.
Could ASEAN Become Next Priority For Korean Pharma Firms?
Southeast Asia has so far not been a priority market for South Korean pharma firms, largely because of challenges such as access and affordability for patients. But a Deloitte executive suggested at a recent seminar that technology-based medicines, for example using next-generation formulation technologies, could be an initial focus for Korean firms looking to enter the rapidly growing ASEAN grouping.